| 1 |
34259987 | Activation of autophagy reverses gemcitabine-induced immune inhibition of RAW264.7 macrophages by promoting TNF-α, IL-6 and MHC-II expression. | 2021 Aug |
2 |
| 2 |
34771621 | CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells. | 2021 Oct 30 |
1 |
| 3 |
31853779 | Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self-Producing Cytokines. | 2020 Oct |
2 |
| 4 |
29693005 | Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells. | 2018 |
5 |
| 5 |
28007550 | Gemcitabine: Selective cytotoxicity, induction of inflammation and effects on urothelial function. | 2017 Feb 1 |
1 |
| 6 |
27655706 | The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma. | 2016 Nov 15 |
1 |
| 7 |
27687804 | Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer. | 2016 Sep 29 |
1 |
| 8 |
25609203 | Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells. | 2015 Feb 20 |
1 |
| 9 |
24953430 | Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer. | 2014 Jun |
2 |
| 10 |
23298711 | Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer. | 2013 May |
1 |
| 11 |
23591198 | Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. | 2013 May 28 |
1 |
| 12 |
22420547 | Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors. | 2012 Jan |
1 |
| 13 |
21408027 | Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. | 2011 Mar 9 |
1 |
| 14 |
18430611 | Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells. | 2008 Jun |
2 |
| 15 |
12479703 | Caspase activation is required for gemcitabine activity in multiple myeloma cell lines. | 2002 Nov |
1 |
| 16 |
10854139 | New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production. | 2000 |
3 |